tradingkey.logo
tradingkey.logo
Search

OS Therapies Inc

OSTX
Add to Watchlist
1.520USD
0.0000.00%
Close 07-27 16:00ETQuotes delayed by 15 min
69.67MMarket Cap
LossP/E TTM

OSTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of OS Therapies Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-32.59%-4.56M
-57.09%-3.73M
-39.04%-4.71M
-167.85%-2.36M
-436.35%-3.44M
-172.58%-2.37M
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
42.80%-871.16K
---876.57K
---831.05K
55.44%-428.19K
---1.52M
---960.91K
Net income from continuing operations
-168.18%-10.40M
-350.01%-13.46M
-139.27%-6.88M
-191.28%-4.54M
-165.72%-3.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
42.61%-1.46M
---1.97M
---2.51M
-35.56%-1.85M
---2.55M
---1.36M
Operating gains losses
17876.69%124.94K
8888.35%124.94K
--124.94K
16089.06%112.51K
0.00%695.00
--1.39K
-100.00%0.00
-13.66%695.00
595.00%695.00
-100.00%0.00
--3.31K
--805.00
--100.00
--805.00
--0.00
Other non-cash items
272.42%358.17K
-100.00%0.00
-29.28%239.25K
-157.41%-292.04K
-135.90%-207.74K
-84.28%33.52K
-65.52%338.29K
-39.15%508.65K
-21.03%578.74K
-78.42%213.24K
--981.14K
--835.93K
194.20%732.84K
--988.01K
--249.09K
Change in working capital
1408.15%3.91M
2452.64%8.00M
217.26%994.22K
769.00%1.45M
-225.83%-299.26K
-17.55%313.44K
-843.97%-847.86K
-80.06%166.94K
-65.32%237.83K
845.45%380.17K
--113.96K
--837.27K
349.68%685.84K
--40.21K
--152.52K
-Change in prepaid expenses
--63.08K
871.80%340.13K
1096.43%348.75K
--348.75K
----
--35.00K
---35.00K
----
----
----
----
----
----
----
----
-Change in other current assets
----
----
----
----
----
--77.50K
---15.37K
---62.13K
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-32.59%-4.56M
-57.09%-3.73M
-39.04%-4.71M
-167.85%-2.36M
-436.35%-3.44M
-172.58%-2.37M
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
42.80%-871.16K
---876.57K
---831.05K
55.44%-428.19K
---1.52M
---960.91K
Investing cash flow
Net cash from continuing investing activities
----
--0.00
--0.00
--466.42K
----
----
--0.00
----
----
---19.00
--0.00
--19.00
----
----
----
Capital expenditures
----
--0.00
--0.00
--466.42K
----
----
--0.00
----
----
----
--0.00
--19.00
----
----
----
Net cash flow from disposal of fixed assets
----
--0.00
--0.00
--466.42K
----
----
--0.00
----
----
---19.00
--0.00
--19.00
----
----
----
Net cash flow from investment products
----
----
----
--150.00K
---150.00K
----
----
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
----
--0.00
--0.00
--23.64K
---23.64K
--0.00
--0.00
----
----
--0.00
--0.00
--0.00
--1.15K
--0.00
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
----
--0.00
--0.00
---292.79K
---173.64K
-100.00%0.00
--0.00
----
----
--19.00
--0.00
---19.00
--1.15K
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
394.90%5.21M
-64.90%2.12M
-26.56%3.78M
183.60%2.48M
49.79%1.05M
576.69%6.05M
510.38%5.15M
66.81%875.88K
15.10%702.98K
-45.99%894.06K
--843.41K
--525.08K
-33.97%610.77K
--1.66M
--925.00K
Net cash flow from debt Issuance/repayment
--1.83M
----
----
----
-100.00%0.00
-100.00%0.00
-130.30%-250.00K
84.62%900.00K
9.81%851.00K
-43.46%1.07M
--825.00K
--487.50K
-16.22%775.00K
--1.89M
--925.00K
Net cash flow from common stock issuance/repurchase
--3.38M
--530.16K
----
----
----
--0.00
--5.23M
----
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
--0.00
--582.00
--1.05M
--6.05M
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
--3.38M
--1.59M
--3.78M
--2.48M
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
--0.00
---582.00
-100.00%0.00
----
100.00%0.00
100.00%0.00
835.22%172.14K
-164.17%-24.11K
9.87%-148.02K
25.77%-175.94K
--18.41K
--37.58K
---164.22K
---237.02K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
394.90%5.21M
-64.90%2.12M
-26.56%3.78M
183.60%2.48M
49.79%1.05M
576.69%6.05M
510.38%5.15M
66.81%875.88K
15.10%702.98K
-45.99%894.06K
--843.41K
--525.08K
-33.97%610.77K
--1.66M
--925.00K
Net cash flow
Beginning cash balance
-95.12%269.83K
1.00%1.88M
2851.82%2.80M
2864.16%2.97M
14095.08%5.53M
11470.48%1.86M
92.85%94.92K
-71.78%100.23K
-77.27%38.98K
-59.01%16.06K
--49.22K
--355.21K
112.26%171.48K
--39.18K
--80.79K
Current period cash flow changes
125.28%647.72K
-143.72%-1.61M
-152.48%-925.39K
-3084.96%-168.99K
-4283.77%-2.56M
15933.78%3.68M
5416.71%1.76M
98.27%-5.31K
-66.66%61.25K
-82.67%22.92K
---33.16K
---305.99K
611.68%183.73K
--132.30K
---35.91K
Ending cash balance
-69.12%917.55K
-95.12%269.83K
1.00%1.88M
2851.82%2.80M
2864.16%2.97M
14095.08%5.53M
11470.48%1.86M
92.85%94.92K
-71.78%100.23K
-77.27%38.98K
--16.06K
--49.22K
691.48%355.21K
--171.48K
--44.88K
Free cash flow
----
-57.09%-3.73M
-39.04%-4.71M
---2.83M
---3.44M
-172.58%-2.37M
-286.14%-3.38M
----
----
42.80%-871.16K
---876.57K
---831.07K
55.44%-428.19K
---1.52M
---960.91K
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did OS Therapies Inc Generate?

OS Therapies Inc generated -14.24M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did OS Therapies Inc's Operating Cash Flow Change Year Over Year?

OS Therapies Inc's operating cash flow increased by -95.52% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does OS Therapies Inc Spend on Capital Expenditures?

OS Therapies Inc spent 466.42K on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has OS Therapies Inc's Financing Cash Flow Changed?

OS Therapies Inc used 9.44M in financing activities in the latest quarter.

What is free cash flow and why does it matter for OSTX?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was OS Therapies Inc’s free cash flow in the latest quarter?

Free cash flow was -14.70M reflecting a -101.93% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.